Regional

Ocala/Marion County/The Villages Public Safety EMS

Current176 dose entries50 drugs1 documentOcala, FLeffective 2025-07-0198% machine-parsed of 176

Ocala/Marion County/The Villages Public Safety EMS (Ocala, FL) carries 50 drugs across 176 dose entries in its current published protocol, effective 2025-07-01.

Drugs and doses50

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	650 mg	PO	not captured	standing	pages 124, 390
Fever	peds	15 mg/kg	PO	not captured	standing	pages 124, 390
Hyperthermia	adult	650 mg	PO	not captured	standing	pages 124, 390
Hyperthermia	peds	15 mg/kg	PO	not captured	standing	pages 124, 390
Sepsis	adult	650 mg	PO	not captured	standing	pages 67, 126, 390
Sepsis	peds	15 mg/kg	PO	not captured	standing	pages 67, 126, 390

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	page 349
SVT	peds	0.1 mg/kg	IV	not captured	standing	page 349

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	2.5 mg	NEB	not captured	standing	page 20
Allergic reaction	adult	2.5 mg	NEB	not captured	standing	page 20
Allergic reaction	peds	2.5 mg	NEB	not captured	standing	page 20
Allergic reaction	peds	2.5 mg	NEB	not captured	standing	page 20
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 62, 63, 103, 118
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 62, 63, 103, 118
Beta-blocker / calcium-channel-blocker overdose	adult	2.5 mg	NEB	not captured	standing	page 59
Hyperkalemia	adult	5–10 mg	NEB	not captured	standing	page 45

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	5 mg/kg	IV/IO	not captured	standing	pages 32, 350
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 39, 350
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 31, 350
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 31, 350

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 41, 351

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV	not captured	standing	pages 36, 37, 110, 352
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 36, 37, 110, 352
Organophosphate poisoning	adult	1–2 mg	IV	not captured	standing	page 352

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV/IO	not captured	standing	pages 59, 353
Hyperkalemia	adult	1 g	IV	not captured	standing	pages 45, 353
Other	adult	500 mg	IV	not captured	standing	page 187

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mL	IV/IO	not captured	standing	pages 22, 105, 124
Hypoglycemia	peds	5 mL/kg	IV/IO	not captured	standing	pages 22, 105, 124

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2–4 mg	IV/IM	not captured	standing	pages 23, 354
Agitation	peds	0.2 mg/kg	IV/IM	not captured	standing	pages 23, 354

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	IV	not captured	standing	page 355
Other	adult	10 mg	IV	not captured	standing	page 355
Other	adult	10 mg	IV	not captured	standing	page 355

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	50 mg	IM	not captured	standing	pages 69, 356
Allergic reaction	adult	25–50 mg	IV/IM	not captured	standing	pages 20, 102, 356
Allergic reaction	peds	1 mg/kg	IV/IM	not captured	standing	pages 20, 102, 356
Nausea / vomiting	adult	50 mg	IV	not captured	standing	pages 53, 356
Other	adult	50 mg	IV/IM	not captured	standing	pages 44, 356

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	page 69

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 20, 103, 359
Anaphylaxis	adult	0.3 mg	IV	not captured	standing	pages 20, 103, 359
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 20, 103, 359
Anaphylaxis	peds	0.01 mg/kg	IV	not captured	standing	pages 20, 103, 359
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	pages 62, 63
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 36, 110, 358
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 29, 31, 109, 358
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 29, 31, 109, 358
Hypotension / shock	adult	0.01 mg	IV/IO	not captured	standing	pages 32, 34, 64
Sepsis	adult	0.01 mg	IV/IO	not captured	standing	pages 67, 126

Esmolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	500 mcg/kg	IV	not captured	standing	page 42

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
Procedural sedation	adult	0.3 mg/kg	IV/IO	not captured	standing	page 360
Procedural sedation	peds	0.3 mg/kg	IV/IO	not captured	standing	page 360
RSI induction	adult	0.3 mg/kg	IV/IO	not captured	standing	pages 162, 360
RSI induction	peds	0.3 mg/kg	IV/IO	not captured	standing	pages 162, 360

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	25–100 mcg	IV/IO	not captured	standing	pages 15, 41, 83, 86, 88, 135, 137, 361
Mild to moderate pain	adult	25–100 mcg	IM	not captured	standing	pages 15, 361
Mild to moderate pain	adult	25–100 mcg	IN	not captured	standing	pages 15, 83, 88, 135, 137, 361

Fosphenytoin

Indication	Population	Dose	Route	Repeat	Standing	Source
Status epilepticus	adult	15–20 mg	IM	not captured	standing	page 362
Status epilepticus	adult	15–20 mg/kg	IV	not captured	standing	page 362
Status epilepticus	peds	15–20 mg	IM	not captured	standing	page 362
Status epilepticus	peds	15–20 mg/kg	IV	not captured	standing	page 362

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	3–5 mg	IV/IO/IM	not captured	standing	page 59
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 105, 362
Hypoglycemia	peds	0.5 mg	IM	not captured	standing	pages 105, 362

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	page 69

Heparin Sodium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	60–80 unit/kg	IV	not captured	standing	page 363
Other	adult	60–80 unit/kg	IV	not captured	standing	page 363
Other	adult	60–80 unit/kg	IV	not captured	standing	page 363
Other	adult	60–80 unit/kg	IV	not captured	standing	page 363
Other	adult	60–80 unit/kg	IV	not captured	standing	page 363
Other	peds	50 unit/kg	IV	not captured	standing	page 363
Other	peds	50 unit/kg	IV	not captured	standing	page 363
Other	peds	50 unit/kg	IV	not captured	standing	page 363
Other	peds	50 unit/kg	IV	not captured	standing	page 363
Other	peds	50 unit/kg	IV	not captured	standing	page 363

Hydralazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5–10 mg	IV	not captured	standing	page 57

Hydromorphone

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.5 mg	IV/IM	not captured	standing	pages 15, 365

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 366
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	page 366

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	pages 62, 63, 103, 118
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	pages 62, 63, 103, 118
COPD	adult	0.5 mg	NEB	not captured	standing	pages 62, 63, 103, 118
COPD	peds	0.5 mg	NEB	not captured	standing	pages 62, 63, 103, 118

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2–4 mg/kg	IM	not captured	standing	pages 69, 367
RSI induction	adult	2 mg/kg	IV/IO	not captured	standing	pages 162, 164, 367
RSI induction	peds	2 mg/kg	IV/IO	not captured	standing	pages 162, 164, 367

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	0.2 mg/kg	IV/IO	not captured	standing	page 57
Other	adult	10 mg	IV	not captured	standing	page 47
Other	adult	10 mg	IV	not captured	standing	page 388

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1 mg	IV/IM	not captured	standing	pages 23, 66, 369
Agitation	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 23, 66, 369

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV/IO	not captured	standing	pages 62, 63, 370
Asthma / bronchospasm	peds	2 g	IV/IO	not captured	standing	pages 62, 63, 370
Eclampsia / pre-eclampsia	adult	2–4 g	IV/IO	not captured	standing	pages 57, 370
Other	adult	2 g	IV/IO	not captured	standing	page 31
Other	adult	2 g	IV/IO	not captured	standing	page 49

Mannitol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.25–0.5 g/kg	IV	not captured	standing	pages 75, 371
Other	adult	0.25–0.5 g/kg	IV	not captured	standing	page 371
Other	adult	0.25–0.5 g/kg	IV	not captured	standing	page 371
Other	adult	0.25–0.5 g/kg	IV	not captured	standing	page 371
Other	peds	0.5–1 g/kg	IV	not captured	standing	pages 75, 371
Other	peds	0.5–1 g/kg	IV	not captured	standing	page 371
Other	peds	0.5–1 g/kg	IV	not captured	standing	page 371
Other	peds	0.5–1 g/kg	IV	not captured	standing	page 371

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV	not captured	standing	page 19
Allergic reaction	adult	125 mg	IV	not captured	standing	pages 20, 103, 372
Allergic reaction	peds	2 mg/kg	IV	not captured	standing	pages 20, 103, 372
Asthma / bronchospasm	adult	125 mg	IV	not captured	standing	pages 62, 63, 119, 372
Asthma / bronchospasm	peds	2 mg/kg	IV	not captured	standing	pages 62, 63, 119, 372
COPD	adult	125 mg	IV	not captured	standing	pages 62, 63, 372

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IV/IO	not captured	standing	page 41

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2–4 mg	IV/IM	not captured	standing	page 23
Agitation	adult	5 mg	IM	not captured	standing	page 69
Procedural sedation	adult	2 mg	IV/IN	not captured	standing	page 206
Procedural sedation	adult	2–4 mg	IV/IO/IM	not captured	standing	pages 37, 203
Procedural sedation	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 37, 203
Procedural sedation	peds	0.1 mg/kg	IV/IN	not captured	standing	page 206
RSI induction	adult	2–4 mg	IV	not captured	standing	page 162
Seizure	adult	2–4 mg	IV/IO/IM	not captured	standing	pages 23, 66, 124
Seizure	peds	0.2 mg/kg	IN	not captured	standing	page 124

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	2 mg	IV/IO	not captured	standing	pages 22, 23, 106, 376
Opioid overdose	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 22, 23, 106, 376
Opioid overdose	peds	2 mg	IN	not captured	standing	pages 23, 106, 376

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 41, 377
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 64, 377
CHF / pulmonary edema	adult	1 inch	TOP	not captured	standing	pages 64, 377

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiogenic shock	adult	0.05 mcg/kg	IV/IO	not captured	standing	page 380
Hypotension / shock	adult	0.05 mcg/kg	IV/IO	not captured	standing	pages 67, 380
Hypotension / shock	adult	0.05 mcg/kg	IV/IO	not captured	standing	page 380
Sepsis	peds	0.05–0.1 mcg/kg	IV/IO	not captured	standing	page 126

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV	not captured	standing	pages 15, 17, 53, 75, 113, 135, 137, 381
Nausea / vomiting	adult	4 mg	IM	not captured	standing	pages 53, 381
Nausea / vomiting	adult	4 mg	SL	not captured	standing	pages 17, 53, 381
Nausea / vomiting	peds	2 mg	IV	not captured	standing	pages 15, 17, 53, 75, 113, 135, 137, 381
Mild to moderate pain	adult	4 mg	IV	not captured	standing	pages 15, 41, 83, 88, 135, 137, 361, 362

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	page 22

Phenobarbital

Indication	Population	Dose	Route	Repeat	Standing	Source
Seizure	adult	10–20 mg/kg	IV	not captured	standing	page 382
Status epilepticus	adult	10–20 mg/kg	IV	not captured	standing	page 382
Status epilepticus	peds	5–20 mg/kg	IV	not captured	standing	page 382

Phenylephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiogenic shock	adult	50 mcg	IV	not captured	standing	page 382
Cardiogenic shock	peds	0.1–0.5 mcg/kg	IV	not captured	standing	page 382
Hypotension / shock	adult	50 mcg	IV	not captured	standing	page 382
Hypotension / shock	adult	50 mcg	IV	not captured	standing	page 382
Hypotension / shock	adult	50 mcg	IV	not captured	standing	page 382
Hypotension / shock	peds	0.1–0.5 mcg/kg	IV	not captured	standing	page 382
Hypotension / shock	peds	0.1–0.5 mcg/kg	IV	not captured	standing	page 382
Hypotension / shock	peds	0.1–0.5 mcg/kg	IV	not captured	standing	page 382

Phenytoin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	15–20 mg/kg	IV	not captured	standing	page 383
Other	peds	15–20 mg/kg	IV	not captured	standing	page 383
Seizure	adult	15–20 mg/kg	IV	not captured	standing	page 383
Seizure	peds	15–20 mg/kg	IV	not captured	standing	page 383
Status epilepticus	adult	15–20 mg/kg	IV	not captured	standing	page 383
Status epilepticus	peds	15–20 mg/kg	IV	not captured	standing	page 383

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	12.5 mg	IV	not captured	standing	page 53

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1 mg/kg	IV/IO	not captured	standing	pages 162, 164

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	peds	1 mEq/kg	IV/IO	not captured	standing	page 109
Hyperkalemia	adult	50 mEq	IV	not captured	standing	page 45
Tricyclic overdose	adult	50 mEq	IV	not captured	standing	page 59

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1–1.5 mg/kg	IV	not captured	standing	pages 162, 163, 164, 384, 385

Terbutaline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.25 mg	SQ	not captured	standing	page 386
Other	adult	0.25 mg	SQ	not captured	standing	page 386

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 drop	not captured	not captured	standing	pages 90, 387
Other	adult	2 drop	not captured	not captured	standing	pages 90, 387
Other	peds	1 drop	not captured	not captured	standing	pages 90, 387
Other	peds	1 drop	not captured	not captured	standing	pages 90, 387

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	IV/IM	not captured	standing	page 387
Other	adult	100 mg	IV/IM	not captured	standing	page 387
Other	adult	100 mg	IV/IM	not captured	standing	page 387

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV	not captured	standing	pages 54, 56
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	pages 78, 389

Vasopressin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	40 unit	IV/IO	not captured	standing	page 390
Other	adult	40 unit	IV/IO	not captured	standing	page 390
VF / pulseless VT	adult	40 unit	IV/IO	not captured	standing	page 390

Vecuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.1 mg/kg	IV/IO	not captured	standing	page 164
RSI induction	adult	0.05–0.1 mg/kg	IV/IO	not captured	standing	pages 160, 164

Cite this

Ocala/Marion County/The Villages Public Safety EMS, United States EMS Protocol Census. 176 dose entries, effective 2025-07-01.

https://protoquiz.com/census/agencies/ocala-marion-county-the-villages-public-safety-ems/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.